Prosensa Company Profile

Aggregated data from the web about Prosensa

Company Name	Prosensa
Website	https://en.wikipedia.org
Snippet	Prosensa was a biotechnology company engaged in the discovery, development and commercialization of RNA-modulating therapeutics. The company targets genetic disorders with a large unmet medical need, with a primary focus on neuromuscular and neurodegenerative disorders such as Duchenne muscular dystrophy (DMD), myotonic dystrophy, and Huntington's disease.
Type	Public
Founded	2002
Website	www.prosensa.com
Industry	Biotechnology
Products	Pharmaceuticals
Traded as	NASDAQ: RNA
Key people	Hans Schikan (CEO), Berndt Modig (CFO), Giles Champion (CMO), Luc Dochez (CBO) David Mott (Chairman)
Headquarters	Leiden, Netherlands
Number of employees	89 (2014)

Prosensa is part of the Netherlands company list

Prosensa is part of the Biotechnology company list

Have a list of company names and need to update information? Use our Company Search tool.

Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.